XML 77 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisition of Assets (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 28, 2023
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Asset Acquisition [Line Items]          
Research and development     $ 30,532 $ 12,203  
Cerveau Technologies, Inc          
Asset Acquisition [Line Items]          
Payment for acquisitions $ 35,300        
Consideration 10,000        
Asset acquisition, additional milestone payments $ 51,000        
Cerveau Technologies, Inc | Sales Milestones          
Asset Acquisition [Line Items]          
Asset acquisition, additional milestone payments   $ 1,200,000      
Cerveau Technologies, Inc | Research Revenue Milestones          
Asset Acquisition [Line Items]          
Asset acquisition, additional milestone payments   13,500      
POINT Biopharma          
Asset Acquisition [Line Items]          
Payment for acquisitions   260,000      
Asset acquisition, additional milestone payments   1,800,000      
Research and development         $ 260,000
PNT2002 License Agreement          
Asset Acquisition [Line Items]          
Payment for acquisitions   $ 250,000      
Royalty percentage   20.00%      
PNT2002 License Agreement | Sales Milestones          
Asset Acquisition [Line Items]          
Asset acquisition, additional milestone payments   $ 1,300,000      
PNT2002 License Agreement | Regulatory Milestones          
Asset Acquisition [Line Items]          
Asset acquisition, additional milestone payments   281,000      
PNT2003 License Agreement          
Asset Acquisition [Line Items]          
Payment for acquisitions   $ 10,000      
Royalty percentage   15.00%      
PNT2003 License Agreement | Sales Milestones          
Asset Acquisition [Line Items]          
Asset acquisition, additional milestone payments   $ 275,000      
PNT2003 License Agreement | Regulatory Milestones          
Asset Acquisition [Line Items]          
Asset acquisition, additional milestone payments   $ 34,500